Anindya Gupta

Structured products are tailored financial instruments that combine traditional securities like bonds or stocks with one or more derivative components, offering investors customized risk-return profiles that standard investments can't match. Currently, the industry is at a technological...

In the era of precision medicine and on-demand experiences, intelligent content management is the nervous system of pharma innovation and engagement. By seamlessly connecting data, insights, and knowledge across the organization, it accelerates discovery, enhances decision-making, and ultimate...

Discover how to unlock new revenue streams through embedded finance. Learn to leverage APIs, AI, and strategic partnerships to integrate financial services seamlessly, and equip yourself to transform everyday interactions into profitable opportunities.

Against the backdrop of escalating healthcare costs, surpassing $6 trillion by 2028, and a looming shortage of 10 million health workers by 2030, the urgency of 100% digital health integration is stark. This alarming trajectory demands a shift towards prevention and proactive care to curtail skyroc...

Financial services face significant risks from cybercriminals due to insecure cloud and DevOps practices, leading to data theft, financial losses, and reputational damage. Download our whitepaper to discover effective strategies for securing your ecosystem, from identification and protection to res...

In the pharma industry, composable commerce acts as a powerful alchemist, blending potent ingredients into a personalized elixir of success. Like a skilled alchemist mixing precise elements to create transformative potions, composable commerce seamlessly combines diverse digital capabilities, empow...

In a world where artificial intelligence (AI) is transforming industries, the pharmaceutical sector faces unique challenges in fully embracing this technological revolution. Often, the industry experiences a multitude of isolated AI pilot projects that struggle to transition into full-scale product...

The pharma and life sciences industry is experiencing a data revolution. As everything becomes more digital, the amount of biomedical data is exploding. This presents an opportunity to tap into valuable insights to advance R&D, manufacturing, marketing, and more. However, companies struggle to...